TAVAFLOX 

TAVAFLOX 

DCI : LEVOFLOXACIN

Dosage 500 mg 
Pharmaceutical form Divisible coated tablet
Therapeutic class Infectiology
B/5 
Indications

They are limited in the adult treatment of bacterial infections caused by bacteria susceptible to levofloxacin such as: - Acute sinusitis second line - Acute exacerbation of chronic bronchitis - Community-acquired pneumonia bacteremic or not a second-line in adults without risk factors Special situations: Healing anthrax treatment

Download the leaflet

Similar Products

AZRO 
AZRO 
AZRO 600 mg 
AZRO 600 mg 
AZRO 900 mg 
AZRO 900 mg 
AZRO 1500 mg 
AZRO 1500 mg 
LAMISIL 
LAMISIL 
SIFLOKS 
SIFLOKS 
SIFLOKS 
SIFLOKS 
TAVAFLOX 
TAVAFLOX 
ZELIVIR
ZELIVIR
ZELIVIR
ZELIVIR